Home › Funds › Goehring & Rozencwajg Associates, LLC › NTR

Goehring & Rozencwajg Associates, LLC position in NTR

NUTRIEN LTD · Industrials

Goehring & Rozencwajg Associates, LLC reported holding 1,684,602 shares of NTR (NUTRIEN LTD) in its Q3 2026 13F filing — a position valued at US$118.3M, representing 6.29% of its reported portfolio and ranking #3 among its reported holdings. Goehring & Rozencwajg Associates, LLC has disclosed NTR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.68M sh
Reported value held$118.34M
Portfolio Weight6.29%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Goehring & Rozencwajg Associates, LLC's NTR position evolved

Goehring & Rozencwajg Associates, LLC first disclosed a stake in NTR in Q3 2023 at 103,826 shares (US$6.4M). The position peaked in Q3 2026 at 1,684,602 shares, worth US$118.3M. Across 13 filings, Goehring & Rozencwajg Associates, LLC increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,684,602 shares valued at US$118.3M — an increase of 229,583 shares quarter over quarter.. Notable position changes include a 73% increase in Q4 2023 (shares fell 4% over the following quarter), a 235% increase in Q1 2025 (shares rose 17% over the following quarter), a 77% increase in Q2 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 103.83K $6.41M New
Q4 2023 179.26K $10.10M Add
Q1 2024 185.68K $10.08M Add
Q2 2024 203.18K $10.34M Add
Q3 2024 212.30K $10.20M Add
Q4 2024 200.44K $9.00M Reduce
Q1 2025 671.83K $35.24M Add
Q2 2025 781.07K $45.49M Add
Q3 2025 780.24K $45.81M Hold
Q4 2025 825.44K $50.95M Add
Q1 2026 822.29K $62.05M Hold
Q2 2026 1.46M $91.59M Add
Q3 2026 1.68M $118.34M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NTR and 13F data

NTR (NUTRIEN LTD) is a Industrials company. 28 other funds we track also report a position in NTR — the largest reported positions include First Eagle Investment Management (US$702.6M), MACKENZIE FINANCIAL CORP (US$561.8M), TD ASSET MANAGEMENT INC (US$500.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NTR

All NTR fund holders →

FAQ

How long has Goehring & Rozencwajg Associates, LLC held NTR?

Goehring & Rozencwajg Associates, LLC has disclosed NTR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Goehring & Rozencwajg Associates, LLC's current position in NTR?

As of Q3 2026, Goehring & Rozencwajg Associates, LLC holds 1.68M shares of NTR (NUTRIEN LTD), valued at $118.34M, representing 6.29% of its reported portfolio and ranking #3.

Has Goehring & Rozencwajg Associates, LLC been buying or selling NTR?

In the latest 13F filing (Q3 2026), Goehring & Rozencwajg Associates, LLC increased its position in NTR. The position peaked in Q3 2026 at 1.68M shares.

Which other funds hold NTR?

Other major institutional holders of NTR include First Eagle Investment Management, MACKENZIE FINANCIAL CORP, TD ASSET MANAGEMENT INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.